Incarvillateine is a natural compound known for its pain-relieving properties. However, researchers have discovered that it worsens epileptic seizures by inhibiting a type of receptor in the brain called γ-Aminobutyric acid type A (GABA). The researchers conducted experiments on frog eggs and hippocampal slices, and also injected incarvillateine into the brains of rats. They found that the compound inhibited GABA currents and synaptic transmissions, leading to an increase in epileptic activity. This study sheds light on the molecular effects of incarvillateine and its potential negative impact on patients with epilepsy.